FORMULATION, OPTIMIZATION, AND EVALUATION OF IN-SITU GEL OF MOXIFLOXACIN HYDROCHLORIDE FOR OPHTHALMIC DRUG DELIVERY
Objective: The present study emphasizes the synthesis, optimization, and evaluation of ocular in-situ gel for ophthalmic drug delivery against conjunctivitis.
Methods: Pre-formulation studies on the drug and polymers were carried out, which included the study of various physicochemical properties of the drug and drug-polymer compatibility studies. The 12 different formulations were further pre-optimised by Taguchi method for determining the number of influential factors. Furthermore, the formulation optimization was done by using ‘Box–Behnken’ design (BBD) (Design expert 10 software) for assessing the effect of formulation variables on product characteristics viz. viscosity, gelation temperature (GT), and mean release time (MRT). About 13 suggested runs of the experiment were carried out and formulations were optimised. Finally, three batches of the optimised formulation were prepared and evaluated for in vitro drug release, isotonicity of formulation, anti-microbial potential, ocular irritancy, and accelerated stability testing.
Results: Pre-formulation study confirmed the purity, solubility, and compatibility of drug measured by λmax, partition coefficient, stability study, and Fourier-transform infrared spectroscopy (FTIR) analysis. Taguchi screening method suggested about 12 different formulations and 3 most prominent influential factors including viscosity, GT, and drug release. 13 different formulations designed based on ‘BBD’ method were further optimised by considering the most influential factors suggested by Taguchi screening. The in vitro evaluation of the optimised formulation gave satisfactory results in terms of drug release, and anti-microbial activity. It was found to be isotonic with no ocular irritancy. Further, the preparation immediately transformed from sol to gel upon administration into cul-de-sac region of the eye due to multi-dimensional approaches utilised for in-situ gel formation namely temperature change Pluronic, ion sensitivity due to Gellan-gum, pH sensitivity because of Carbopol.
Conclusion: The optimised in-situ gelling ocular drug formulation showed promising potency for ophthalmic drug delivery with no irritancy due to the multifactorial mechanism.
2. Fakhari A, Corcoran M, Schwarz A. Thermogelling properties of purified poloxamer 407. Heliyon 2017;3:e00390.
3. Al-Bazzaz FY, Al-Kotaji M. Opthalmic in-situ sustain gel of ciprofloxacin, preparation and evaluation study. Int J Appl Pharm 2018;4:153-61.
4. Pucker AD, Ng SM, Nichols JJ. Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Syst Rev 2016;2:CD009729.
5. Basavaraj S, Betageri GV. Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges. Acta Pharm Sin B 2014;4:3-17.
6. Kumar S, Himmelstein KJ. Modification of in situ gelling behaviour of carbopol solutions by hydroxypropyl methylcellulose. J Pharm Sci 1995;84:344-8.
7. Rojek B, Wesolowski M. FTIR and TG analyses coupled with factor analysis in a compatibility study of acetazolamide with excipients. Spectrochim Acta A Mol Biomol Spectrosc 2018;13:285-93.
8. Ashengroph M, Nahvi I, Amini J. Application of taguchi design and response surface methodology for improving conversion of isoeugenol into vanillin by resting cells of psychrobacter sp. CSW4. Iran J Pharm Res 2013;12:411-21.
9. Taran M, Rad M, Alavi M. Biosynthesis of TiO2 and ZnO nanoparticles by halomonaselongata IBRC-M 10214 in different conditions of medium. BioImpacts 2018;8:81-9.
10. Gupta C, Juyal V, Nagaich U. Formulation and optimization of in-situ in-situ gel of moxifloxacin hydrochloride for ocular drug delivery. Int J Appl Pharm 2018;10:123-30.
11. Barse RK, Tagalpallewar AA, Kokare CR, Sharma JP, Sharma PK. Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 32 factorial design. Drug Dev Ind Pharm 2018;44:800-7.
12. Shastri DH, Prajapati ST, Patel LD. Thermoreversible mucoadhesive ophthalmic in-situ hydrogel: design and optimisation using a combination of polymers. Acta Pharm 2010;60:349-60.
13. Nahla SB, Ibrahim ME, Alanood SA. Formulation, release characteristics and bioavailability study of oral monolithic matrix tablets containing carbamazepine. AAPS PharmSciTech 2008;9:931–8.
14. Wei G, Xu H, Ding PT, Li SM, Zheng JM. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Controlled Release 2002;83:65-74.
15. Choi HG, Oh YK, Kim CK. In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm 1998;165:23-32.
16. Zabidi MA, Yusoff NM, Kader ZS. Preliminary comparative analysis of antibacterial effects of activated and non-activated of expired platelet concentrate by disc diffusion method. Indian J Pathol Microbiol 2012;55:47-51.
17. Wilhelmus KR. The draize eye test. Surv Ophthalmol 2001;45:493-515.
18. Guo X, Yang XF, Yang Y, Hans R, Cai JH, Xue JY, et al. Prediction of ocular irritancy of 26 chemicals and 26 cosmetic products with isolated rabbit eye (IRE) test. Biomed Environ Sci 2012;25:359-66.
19. Srivastava R, Srivastava S, Singh SP. Thermoreversible in-situ nasal gel formulations and their pharmaceutical evaluation for the treatment of allergic rhinitis containing extracts of moringaolifera and embeliaribes. Int J Appl Pharm 2017;9:16-20.
20. Gao Y, Zuo J, Bou-Chacra N. In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus. Biomed Res Int 2013:1-9. Doi:10.1155/2013/136590
21. Lavanya B, Indira S, Srinivas P. Formulation and evaluation of ocular niosomal in situ gels of linezolid. Int J Pharm Sci Drug Res 2015;7:13-21.
This work is licensed under a Creative Commons Attribution 4.0 International License.